PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pfizer Inc., New York, NY, USA.\', \'Pfizer Inc., Collegeville, PA, USA.\', \'Genesis Research, Hoboken, NJ, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/13696998.2021.2002063
?:doi
?:hasPublicationType
?:journal
  • Journal of medical economics
is ?:pmid of
?:pmid
?:pmid
  • 34844493
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.112
?:rankingScore_hIndex
  • 33
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2.
?:type

Metadata

Anon_0  
expand all